MENU
XENE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xenon Pharmaceuticals (XENE) Ownership - Who owns Xenon Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
200-3650 Gilmore Way
Phone
+1 604 484-3300
Employees
259
Web
https://www.xenon-pharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.15B
P/E Ratio
N/A
Total Cash
654.02M
Projected Growth
N/A
Total Debt
9.79M
Revenue
N/A
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash/Share
8.58
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
XENE
Capitalization
3.15B
P/E Ratio
N/A
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash
654M
Total Cash/Share
8.58
Total Debt
9.79M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
798M
P/B Ratio
3.95
Cash Flow
N/A
Earnings
-2.81
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.44B
Current Ratio
22.21
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-252.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.32
Shares Held By Institutions
5.39B
Shares Outstanding - Current
76.2M
Total Liabilities
38.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
-10.378
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of drug discovery and development services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
200-3650 Gilmore Way
Phone
+1 604 484-3300
Employees
259
Web
https://www.xenon-pharma.com